Healthcare >> CEO Interviews >> July 19, 2004

STEPHEN SIMES – BIOSANTE PHARMACEUTICALS INC (BPA)

STEPHEN M. SIMES has been Vice Chairman, President and CEO of BioSante Pharmaceuticals, Inc., since January 1998. Prior to BioSante, Mr. Simes was President and CEO of Unimed Pharmaceuticals, Inc., and Gynex Pharmaceuticals, Inc., both of which were sold to bigger companies, Unimed to Solvay and Gynex to Bio-Technology General Corp. (now Savient Pharmaceuticals, Inc.). Mr. Simes started his career in the pharmaceutical industry with G.D. Searle & Co. in 1974. Since 1984, he has specialized in emerging companies, building product portfolios in endocrinology, urology, hormones and drug delivery systems, among other areas. Mr. Simes holds a BS in Chemistry from Brooklyn College of the City University of New York and an MBA from New York University. Profile
TWST: Give us a brief overview of your company and BioSante's concept of

drug development.

Mr. Simes: BioSante is developing our product pipeline in order to

increase stockholder value. Our